Home > Healthcare > Medical Devices > Diagnostic Devices > home care testing market
Get a free sample of Home Care Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Home Care Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Recent technological advancements in home care testing are revolutionizing patient monitoring and health management, driving increased demand and usage.
Chembio Diagnostics, Inc, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings, LLC, MP BIOMEDICALS, Nova Biomedical, OraSure Technologies, Inc., Quidel Corp, SA Scientific Ltd, Siemens Healthcare GmbH, and Sterilab Services among others.
North America home care testing market size was USD 4.9 billion in 2023 and is predicted to witness substantial market growth through 2032, driven by the increasing incidence of chronic diseases, such as diabetes, hypertension, and cardiovascular conditions.
Home care testing market size was valued at USD 10.9 billion in 2023 and is estimated to grow at 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of chronic diseases.
The strip segment held a 25.8% revenue share in 2023 and will grow rapidly through 2032, owing to its versatility.